| 상품명칭 |
Saralasin |
| 별명 |
(1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II; N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine; Saralasina; Saralasina [INN-Spanish]; Saralasine; Saralasine [INN-French]; Saralasinum; Saralasinum [INN-Latin]; UNII-H2AFV2HE66; Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-; N-methylglycyl-N~5~-(diaminomethylidene)ornithylvalyltyrosylvalylhistidylprolylalanine; N-methylglycyl-N~5~-(diaminomethylidene)-L-ornithyl-L-valyl-L-tyrosyl-L-valyl-L-histidyl-L-prolyl-L-alanine |
| 분자식 |
C42H65N13O10 |
| 분자량 |
912.0466 |
| InChI |
InChI=1/C42H65N13O10/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47)/t24-,28-,29-,30-,31-,33-,34-/m0/s1 |
| cas번호 |
34273-10-4 |
| 분자 구조 |
|
| 밀도 |
1.42g/cm3 |
| 굴절 지수 |
1.653 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
